CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 231 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $353,134 | +29.7% | 10,869 | +0.6% | 0.00% | – |
Q1 2024 | $272,228 | -23.9% | 10,807 | -1.8% | 0.00% | – |
Q4 2023 | $357,540 | +53.0% | 11,008 | +28.4% | 0.00% | – |
Q3 2023 | $233,653 | +20.2% | 8,576 | -1.8% | 0.00% | – |
Q2 2023 | $194,310 | +16.4% | 8,733 | +13.3% | 0.00% | – |
Q1 2023 | $166,956 | -10.4% | 7,708 | -16.0% | 0.00% | – |
Q4 2022 | $186,304 | -18.3% | 9,173 | +2.6% | 0.00% | – |
Q3 2022 | $228,000 | +35.7% | 8,942 | +25.9% | 0.00% | – |
Q2 2022 | $168,000 | +9.1% | 7,105 | +4.4% | 0.00% | – |
Q1 2022 | $154,000 | +22.2% | 6,807 | +6.3% | 0.00% | – |
Q4 2021 | $126,000 | -9.4% | 6,401 | -9.0% | 0.00% | – |
Q3 2021 | $139,000 | +4.5% | 7,036 | +16.4% | 0.00% | – |
Q2 2021 | $133,000 | -15.8% | 6,044 | -8.2% | 0.00% | – |
Q1 2021 | $158,000 | -7.1% | 6,584 | +1.4% | 0.00% | – |
Q4 2020 | $170,000 | +61.9% | 6,495 | +6.6% | 0.00% | – |
Q3 2020 | $105,000 | 0.0% | 6,093 | -3.5% | 0.00% | – |
Q2 2020 | $105,000 | +50.0% | 6,315 | +7.1% | 0.00% | – |
Q1 2020 | $70,000 | -34.0% | 5,896 | -33.3% | 0.00% | – |
Q4 2019 | $106,000 | -94.0% | 8,834 | -93.0% | 0.00% | -100.0% |
Q3 2019 | $1,773,000 | -2.0% | 125,551 | -22.7% | 0.00% | 0.0% |
Q2 2019 | $1,810,000 | -26.7% | 162,434 | -22.8% | 0.00% | 0.0% |
Q1 2019 | $2,470,000 | -60.2% | 210,521 | -54.7% | 0.00% | -71.4% |
Q4 2018 | $6,203,000 | +5864.4% | 464,312 | +6144.1% | 0.01% | – |
Q3 2018 | $104,000 | -91.2% | 7,436 | -90.1% | 0.00% | -100.0% |
Q2 2018 | $1,179,000 | -0.5% | 75,030 | +4.2% | 0.00% | 0.0% |
Q1 2018 | $1,185,000 | -77.0% | 72,014 | -74.8% | 0.00% | -80.0% |
Q4 2017 | $5,152,000 | -12.5% | 285,365 | -6.5% | 0.01% | -16.7% |
Q3 2017 | $5,891,000 | +4978.4% | 305,179 | +3002.4% | 0.01% | – |
Q2 2017 | $116,000 | +61.1% | 9,837 | +52.6% | 0.00% | – |
Q1 2017 | $72,000 | +3500.0% | 6,447 | +1402.8% | 0.00% | – |
Q2 2016 | $2,000 | 0.0% | 429 | -3.6% | 0.00% | – |
Q1 2016 | $2,000 | 0.0% | 445 | +3.5% | 0.00% | – |
Q4 2015 | $2,000 | 0.0% | 430 | 0.0% | 0.00% | – |
Q3 2015 | $2,000 | -33.3% | 430 | +3.4% | 0.00% | – |
Q2 2015 | $3,000 | +50.0% | 416 | +41.0% | 0.00% | – |
Q1 2015 | $2,000 | – | 295 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,372,001 | $98,287,000 | 4.68% |
TANAKA CAPITAL MANAGEMENT INC | 79,574 | $934,000 | 2.82% |
Consonance Capital Management LP | 3,747,453 | $43,995,000 | 2.78% |
S&T BANK/PA | 613,740 | $7,205,000 | 1.62% |
AJ WEALTH STRATEGIES, LLC | 595,834 | $6,995,000 | 1.16% |
Capital Impact Advisors, LLC | 193,694 | $2,522,000 | 1.12% |
TEALWOOD ASSET MANAGEMENT INC | 154,615 | $1,815,000 | 0.77% |
AMI ASSET MANAGEMENT CORP | 722,932 | $8,487,000 | 0.63% |
Birchview Capital, LP | 50,000 | $587,000 | 0.37% |
FEDERATED HERMES, INC. | 11,176,281 | $131,210,000 | 0.32% |